Abstract:Hemangioblasts are the multipotent progenitors that can differentiate into both hematopoietic and endothelial cells (ECs). Defining the molecular mechanisms underlying specification of hemangioblasts may have great clinical potential for regenerativemedicine because it may lead to new strategies for treating a variety of hematologic and vascular disorders. The existence of hemangioblasts has been demonstrated in human and mouse embryos by the finding that single-cell–derived colonies can generate both hematopoietic and ECs in in vitro differentiation assays of mouse or human embryonic stem cells. Single-cell–resolution fate mapping of late zebrafish blastula and gastrula demonstrated the existence of hemangioblasts that produced both hematopoietic and ECs in vivo. Emerging evidence suggests that hemangioblasts may exist as circulating stem cells in the peripheral blood in the adult. The bipotential hemangioblasts are developed from the mesoderm in the early vertebrate embryo or the ventral mesoderm from zebrafish embryos. Hemangioblasts can then differentiate into either hematopoietic or EC lineages. For specification of the EC lineage, hemangioblasts first differentiate into angioblasts, which then give rise to vascular ECs, including arterial ECs and venous ECs. The hematopoietic lineage will generate blood cells, including erythroid cells, myeloid cells, and lymphoid cells. Early vertebrate embryonic hematopoiesis consisted of 2 stages or waves, the primitive hematopoiesis and definitive hematopoiesis, at different anatomical sites. The first stage of primitive hematopoiesis occurs in the intermediate cell mass in zebrafish. The second wave of definitive hematopoiesis produces adult-type hematopoietic stem cells (HSCs) in major vessels or highly vascularized structures, that is, the aorta-gonad-mesonephros region, umbilical/vitelline arteries, yolk sac, and placenta at the E10-11 stage. In zebrafish, the functionally equivalent structure of the aorta-gonad-mesonephros region is found in the ventral wall of the dorsal aorta marked by expression of c-myb and runx1. The differentiation of hemangioblasts from the mesoderm is regulated by a number of transcriptional factor genes, including several members of the E-twenty six family (etsrp, fli1), scl, and lmo2. Scl/tal1 encodes a basic helix-loop-helix transcription factor and plays an essential role in hematopoiesis and development of the dorsal aorta during zebrafish embryogenesis. Fli1was shown to act upstream of scl to drive blood and EC differentiation.Etsrpwas shown to act upstream of the full-length isoform of scl (scl-a) and fli1 to specify angioblasts or the N-terminal truncated isoform of scl-b to specify HSCs. Lmo2 encodes an LIM-containing protein that forms a complex with Scl/Tal1 to specify the development of hemangioblasts. A number of transcription factors are expressed in the anterior lateral mesoderm and/or the posterior lateral mesoderm and play a critical role in primitive and definitive hematopoiesis. Gata1 and pu.1 encode 2 early transcription factors regulating primitive hematopoiesis. Gata1 is a critical gene in dictating the erythroid

LSD1 promotes the egress of hematopoietic stem and progenitor cells into the bloodstream during the endothelial-to-hematopoietic transition

Gfi1aa/Lsd1 Facilitates Hemangioblast Differentiation into Primitive Erythrocytes by Targeting Etv2 and Sox7 in Zebrafish.

The scaffolding function of LSD1/KDM1A reinforces a negative feedback loop to repress stem cell gene expression during primitive hematopoiesis

LSD1/KDM1A and GFI1B repress endothelial fate and induce hematopoietic fate in induced pluripotent stem cell-derived hemogenic endotheliums

Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation

Histone Demethylase Lsd1 Represses Hematopoietic Stem and Progenitor Cell Signatures During Blood Cell Maturation

GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1

Opposing LSD1 Complexes Function in Developmental Gene Activation and Repression Programmes

Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition

The Transcription Factor ZBP-89 Controls Generation of the Hematopoietic Lineage in Zebrafish and Mouse Embryonic Stem Cells

The Histone Demethylase Jmjd3 Regulates Zebrafish Myeloid Development by Promoting Spi1 Expression.

LSD1 is Required for Hair Cell Regeneration in Zebrafish

Blf and the Drl Cluster Synergistically Regulate Cell Fate Commitment During Zebrafish Primitive Hematopoiesis

Dominant-negative C/ebpα and Polycomb Group Protein Bmi1 Extend Short-Lived Hematopoietic Stem/progenitor Cell Life Span and Induce Lethal Dyserythropoiesis

Gfi1.1 Regulates Hematopoietic Lineage Differentiation During Zebrafish Embryogenesis

LSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16.

LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia

HEMATOPOIESIS AND STEM CELLS Aggf 1 acts at the top of the genetic regulatory hierarchy in speci fi cation of hemangioblasts in zebra fi sh

Abstract 430: An Acyltransferase Controls The Generation Of Hematopoietic And Endothelial Lineages In Zebrafish And Mouse ES Cells

LSD1 controls a nuclear checkpoint in Wnt/β-Catenin signaling to regulate muscle stem cell self-renewal

The scaffolding function of LSD1 controls DNA methylation in mouse ESCs